Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
293 Leser
Artikel bewerten:
(1)

Multiplex Assays Market is expected to generate a revenue of USD 5.33 Billion by 2027, Globally, at 7.1% CAGR: Verified Market Research

Multiplex Assays are used in clinical trials because they reduce the cost of research and manual labour while increasing the efficiency of experiments. Furthermore, they provide easier and faster disease analysis, fueling the market growth.

JERSEY CITY, N.J., Nov. 16, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Multiplex Assays Market" By Product And Service (Equipment And Consumables), By Type (Immunoassays And Chromatography-MS), By Class Of Drug (Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Drugs, And Other Drugs), By End User (Hospital Labs, Commercial Or Private Labs, And Other), By Geographic Scope And Forecast.

Verified Market Research Logo

As per the deep research carried out by Verified Market Research, the global Multiplex Assays Market size was valued at USD 3.20 Billion in 2019 and is projected to reach USD 5.33 Billion by 2027, growing at a CAGR of 7.1% from 2020 to 2027.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=24238

Browse in-depth TOC on "Multiplex Assays Market"

202 - Pages

126 - Tables

37 - Figures

Global Multiplex Assays Market Overview

The Multiplex Assay is a procedure that detects and quantifies multiple analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and so on) at the same time. When compared to traditional methods such as ELISA, this assay is used to amplify multiple targets during a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in less time. Pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and other applications make up the Multiplex Assays Market.

The Multiplex Assay Market is expanding rapidly as a result of increased R&D activities in the pharmaceutical sector for the treatment of various diseases. These assays are used in clinical trials because they reduce the cost of research and manual labour while also increasing the efficiency of experiments and therapies. Furthermore, they provide easier and faster disease analysis and are automated, fueling the Multiplex Assay Market growth. However, high capital investment and a scarcity of skilled labourers are major impediments to market growth. One of the factors driving the growth of this market is technological advancement. Because of the rapid advancement of nanotechnology, this has progressed to the next level of nanoarray, which represents the ultra-miniaturization version of the traditional microarray. The growing recognition of the multifactorial nature of various diseases and pathological conditions such as cancer and Alzheimer's disease has necessitated the development of a cost-effective and time-saving method for measuring multiple analysts in a single sample. This is the driving force behind the global Multiplex Assays Market.

Key Players

The major players in the market are Abbott Laboratories, Hoffmann-La Roche, Siemens Healthineers, Thermo Fisher Scientific, Danaher Corporation, Bio-Rad Laboratories, Biomérieux, Bühlmann Laboratories, Sekisui Medical, Randox Laboratories.

Verified Market Research has segmented the Global Multiplex Assays Market On the basis of Product And Service, Type, Class Of Drug, End-User, and Geography.

  • Multiplex Assays Market, By Product And Service
    • Equipment
    • Consumables
  • Multiplex Assays Market, By Type
    • Immunoassays
    • Chromatography-MS
  • Multiplex Assays Market, By Class Of Drug
    • Antiepileptic drugs
    • Antibiotic drugs
    • Immunosuppressant drugs
    • Antiarrhythmic drugs
    • Bronchodilator drugs
    • Psychoactive drugs
    • Other drugs
  • Multiplex Assays Market, By End User
    • Hospital labs,
    • Commercial or private labs
    • Other
  • Multiplex Assays Market, By Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Lateral Flow Assay Market By Type (Lateral Flow Readers, Kits And Reagents), By Technique (Competitive Assay, Sandwich Assay), By Application (Veterinary Diagnostics, Clinical/Point-Of-Care Testing), By End-User (Home Care, Diagnostic Laboratories, Hospitals And Clinics), By Geography, And Forecast

Specimen Validity Testing Market By Product Type (Assay Kits, Reagents and Calibrators), By End-User (Drug Rehabilitation Centers, Drug Screening Laboratories), By Geography, And Forecast

Stem Cell Assay Market By Product (Reagents And Kits, Instruments), By Application (Regenerative Medicine And Therapy, Clinical Research), By Assay (Cell Identification Assays, Viabilityor Cytotoxicity Assays), By Geography, And Forecast

Protein Assays Market By End User (Hospitals, Clinical Laboratories), By Application (Drug Discovery And Development, Disease Diagnosis), By Technology (Absorbance-Based Protein Assays, Colorimetric-Based Protein Assays), By Product (Reagents, Kits), By Type (Dye-Binding Assays, Copper-Ion-Based Assays), By Geography, And Forecast

Top 10 Microfluidic Immunoassay Companies restructuring medical testing processes worldwide

Visualize Multiplex Assays Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/multiplex-assays-market-is-expected-to-generate-a-revenue-of-usd-5-33-billion-by-2027--globally-at-7-1-cagr-verified-market-research-301680190.html

© 2022 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.